YAP1 and prostate cancer: Pharmacological inhibition of YAP1 nuclear translocation drastically reduced FSTL3 expression and a positive correlation between YAP1 and FSTL3 mRNA expression was very recently shown in prostate cancer (Lee et al., 2017).